Financial Ratios Bharat Rasayan Limited Bombay S.E.
Stocks
BHARATRAS
INE838B01021
Agricultural Chemicals
|
Market Closed -
Bombay S.E.
14:02:24 25/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,095.50 INR | -1.84% |
|
-6.17% | -50.79% |
| 09-21 | Bharat Rasayan Limited(BSE:590021) dropped from S&P Global BMI Index | CI |
| 09-01 | Bharat Rasayan Limited announces Annual dividend, payable on September 24, 2026 | CI |
| Fiscal Period: March | 2017 (INR) | 2018 (INR) | 2019 (INR) | 2020 (INR) | 2021 (INR) | 2022 (INR) | 2023 (INR) | 2024 (INR) | 2025 (INR) | 2026 (INR) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 14.53 | 9.92 | 5.11 | 7.26 | 7.72 | |||||
Return on Total Capital | 16.78 | 11.49 | 5.83 | 8.28 | 8.81 | |||||
Return On Equity % | 23.51 | 14.98 | 10.15 | 13.31 | 12.12 | |||||
Return on Common Equity | 23.51 | 14.98 | 10.15 | 13.31 | 12.12 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 35.24 | 32.02 | 30.98 | 33.76 | 35.11 | |||||
SG&A Margin | 7.14 | 7.2 | 8.32 | 7.45 | 7.45 | |||||
EBITDA Margin % | 19.76 | 15.99 | 11.34 | 15.19 | 16.25 | |||||
EBITA Margin % | 17.85 | 13.89 | 8.88 | 12.89 | 14.14 | |||||
EBIT Margin % | 17.85 | 13.88 | 8.88 | 12.89 | 14.14 | |||||
Income From Continuing Operations Margin % | 13.53 | 10.1 | 9.14 | 12.01 | 11.73 | |||||
Net Income Margin % | 13.53 | 10.1 | 9.14 | 12.01 | 11.73 | |||||
Net Avail. For Common Margin % | 13.53 | 10.1 | 9.14 | 12.01 | 11.73 | |||||
Normalized Net Income Margin | 11.41 | 9 | 7.04 | 9.19 | 9.78 | |||||
Levered Free Cash Flow Margin | -11.42 | 13.85 | -1.07 | 9.97 | 3.1 | |||||
Unlevered Free Cash Flow Margin | -11.09 | 14.14 | -0.89 | 10.22 | 3.33 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.3 | 1.14 | 0.92 | 0.9 | 0.87 | |||||
Fixed Assets Turnover | 5.82 | 5.21 | 4.43 | 4.88 | 4.63 | |||||
Receivables Turnover (Average Receivables) | 3.43 | 3.13 | 2.91 | 2.89 | 3.09 | |||||
Inventory Turnover (Average Inventory) | 3.78 | 2.8 | 2.45 | 2.79 | 2.6 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.59 | 4.64 | 4.6 | 4.19 | 7.78 | |||||
Quick Ratio | 1.6 | 2.54 | 3.11 | 2.97 | 5.19 | |||||
Operating Cash Flow to Current Liabilities | -0.21 | 1.25 | 0.21 | 0.66 | 0.97 | |||||
Days Sales Outstanding (Average Receivables) | 106.5 | 116.62 | 125.9 | 126.47 | 118.25 | |||||
Days Outstanding Inventory (Average Inventory) | 96.54 | 130.57 | 149.68 | 130.83 | 140.63 | |||||
Average Days Payable Outstanding | 24.82 | 29.48 | 40.66 | 48.99 | 51.53 | |||||
Cash Conversion Cycle (Average Days) | 178.23 | 217.71 | 234.93 | 208.31 | 207.35 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 22.55 | 3.13 | 8.15 | 7.54 | 0.1 | |||||
Total Debt / Total Capital | 18.4 | 3.03 | 7.53 | 7.01 | 0.1 | |||||
LT Debt/Equity | 0.13 | - | - | - | - | |||||
Long-Term Debt / Total Capital | 0.11 | - | - | - | - | |||||
Total Liabilities / Total Assets | 29.34 | 16.79 | 17.5 | 19.75 | 11.01 | |||||
EBIT / Interest Expense | 34.06 | 29.51 | 31.38 | 32.08 | 38.22 | |||||
EBITDA / Interest Expense | 37.72 | 34 | 40.1 | 37.8 | 43.96 | |||||
(EBITDA - Capex) / Interest Expense | 29.55 | 29.95 | 30.95 | 30.23 | 27.95 | |||||
Total Debt / EBITDA | 0.68 | 0.14 | 0.68 | 0.48 | 0.01 | |||||
Net Debt / EBITDA | 0.67 | -0.1 | -0.37 | -1.12 | -1.34 | |||||
Total Debt / (EBITDA - Capex) | 0.86 | 0.16 | 0.88 | 0.6 | 0.01 | |||||
Net Debt / (EBITDA - Capex) | 0.86 | -0.12 | -0.48 | -1.41 | -2.11 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 19.15 | -5.13 | -15.37 | 12.29 | 5.87 | |||||
Gross Profit, 1 Yr. Growth % | 12.38 | -13.79 | -18.14 | 22.39 | 10.1 | |||||
EBITDA, 1 Yr. Growth % | 6.7 | -22.08 | -39.92 | 50.38 | 13.28 | |||||
EBITA, 1 Yr. Growth % | 7.84 | -24.95 | -45.84 | 63.02 | 16.06 | |||||
EBIT, 1 Yr. Growth % | 7.88 | -24.95 | -45.83 | 63.05 | 16.06 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 7.39 | -29.19 | -23.35 | 47.54 | 3.41 | |||||
Net Income, 1 Yr. Growth % | 7.39 | -29.19 | -23.35 | 47.54 | 3.41 | |||||
Normalized Net Income, 1 Yr. Growth % | 10.6 | -23.89 | -33.72 | 46.52 | 12.7 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 9.81 | -29.19 | -23.35 | 47.54 | 3.41 | |||||
Accounts Receivable, 1 Yr. Growth % | 56.88 | -29.91 | 21.11 | 6.5 | -8.07 | |||||
Inventory, 1 Yr. Growth % | 64.45 | 16.56 | -17.48 | 8.9 | 13.84 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 14.62 | -1.62 | 0.49 | 3.57 | 19.19 | |||||
Total Assets, 1 Yr. Growth % | 20.04 | -1.1 | 11.53 | 17.6 | 1.73 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.87 | 16.02 | 10.59 | 14.39 | 12.81 | |||||
Common Equity, 1 Yr. Growth % | 5.88 | 16.01 | 10.59 | 14.39 | 12.81 | |||||
Cash From Operations, 1 Yr. Growth % | -138.46 | -425.94 | -80.75 | 318.77 | -23.25 | |||||
Capital Expenditures, 1 Yr. Growth % | 83.04 | -57.78 | 15.04 | 31.89 | 105.96 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -231.43 | -213.24 | -106.54 | -1.15K | -67.12 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -225.11 | -219 | -105.35 | -1.39K | -65.53 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.48 | 6.32 | -10.4 | -2.52 | 9.03 | |||||
Gross Profit, 2 Yr. CAGR % | 10.44 | -1.57 | -15.99 | 0.1 | 16.08 | |||||
EBITDA, 2 Yr. CAGR % | 5.82 | -9.5 | -31.6 | -4.95 | 30.52 | |||||
EBITA, 2 Yr. CAGR % | 5.64 | -10.79 | -36.27 | -6.03 | 37.55 | |||||
EBIT, 2 Yr. CAGR % | 5.74 | -10.77 | -36.26 | -6.02 | 37.56 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 5.66 | -12.8 | -26.33 | 6.34 | 23.52 | |||||
Net Income, 2 Yr. CAGR % | 5.66 | -12.8 | -26.33 | 6.34 | 23.52 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.74 | -9 | -29.02 | -1.45 | 28.5 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 6.84 | -11.82 | -26.33 | 6.34 | 23.52 | |||||
Accounts Receivable, 2 Yr. CAGR % | 36.03 | 4.86 | -7.86 | 13.57 | -1.05 | |||||
Inventory, 2 Yr. CAGR % | 31.49 | 38.45 | -1.92 | -5.2 | 11.34 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 4.01 | 6.19 | -0.57 | 2.02 | 11.11 | |||||
Total Assets, 2 Yr. CAGR % | 20.39 | 8.74 | 5.03 | 14.52 | 9.38 | |||||
Tangible Book Value, 2 Yr. CAGR % | 16.85 | 10.83 | 13.27 | 12.47 | 13.6 | |||||
Common Equity, 2 Yr. CAGR % | 16.83 | 10.83 | 13.27 | 12.47 | 13.59 | |||||
Cash From Operations, 2 Yr. CAGR % | -50.07 | 11.96 | -20.78 | -10.21 | 79.27 | |||||
Capital Expenditures, 2 Yr. CAGR % | -2.37 | -12.09 | -30.31 | 23.18 | 64.82 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -4.87 | 22.97 | -72.79 | -17.27 | 85.47 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -8.92 | 23.03 | -74.78 | -17.11 | 110.46 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 0 | 100 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.46 | 0.53 | -1.47 | -3.4 | 0.2 | |||||
Gross Profit, 3 Yr. CAGR % | 14.12 | 1.69 | -7.44 | -4.77 | 3.33 | |||||
EBITDA, 3 Yr. CAGR % | 11.08 | -4.92 | -21.07 | -11.06 | 0.78 | |||||
EBITA, 3 Yr. CAGR % | 10.82 | -6.26 | -24.48 | -12.84 | 0.82 | |||||
EBIT, 3 Yr. CAGR % | 10.86 | -6.21 | -24.46 | -12.83 | 0.83 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 16.42 | -7.54 | -16.47 | -7.14 | 5.36 | |||||
Net Income, 3 Yr. CAGR % | 16.42 | -7.54 | -16.47 | -7.14 | 5.36 | |||||
Normalized Net Income, 3 Yr. CAGR % | 14.81 | -5.16 | -18.16 | -9.62 | 3.06 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.29 | -6.85 | -15.84 | -7.14 | 5.36 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.44 | 9.06 | 10.02 | -3.31 | 5.84 | |||||
Inventory, 3 Yr. CAGR % | 9.66 | 26.31 | 16.52 | 1.56 | 0.76 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.94 | 2.1 | 4.26 | 0.79 | 7.45 | |||||
Total Assets, 3 Yr. CAGR % | 12.98 | 12.61 | 9.67 | 9.06 | 10.09 | |||||
Tangible Book Value, 3 Yr. CAGR % | 23.56 | 16.57 | 10.75 | 13.64 | 12.59 | |||||
Common Equity, 3 Yr. CAGR % | 23.5 | 16.56 | 10.75 | 13.64 | 12.58 | |||||
Cash From Operations, 3 Yr. CAGR % | 7.76 | -6.69 | -37.74 | 38 | -14.79 | |||||
Capital Expenditures, 3 Yr. CAGR % | 5.26 | -26.17 | -3.85 | -13.8 | 46.2 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 5.75 | 1.36 | -53.76 | -8.16 | -39.17 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 7.63 | 0.12 | -56.75 | -6.51 | -38.13 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 0 | 0 | 0 | 58.74 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.96 | 9.19 | 1.04 | -0.7 | 2.61 | |||||
Gross Profit, 5 Yr. CAGR % | 21.68 | 7.69 | 0.96 | 1.05 | 1.34 | |||||
EBITDA, 5 Yr. CAGR % | 18.4 | 4.52 | -8.78 | -4.94 | -3.48 | |||||
EBITA, 5 Yr. CAGR % | 19.83 | 3.87 | -11.47 | -6.18 | -4.01 | |||||
EBIT, 5 Yr. CAGR % | 19.82 | 3.87 | -11.45 | -6.15 | -4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 26.4 | 4.85 | -3.05 | -2.22 | -2.32 | |||||
Net Income, 5 Yr. CAGR % | 26.4 | 4.85 | -3.05 | -2.22 | -2.32 | |||||
Normalized Net Income, 5 Yr. CAGR % | 23.11 | 5.93 | -5.59 | -3.72 | -1.97 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 26.97 | 5.32 | -2.62 | -1.78 | -1.88 | |||||
Accounts Receivable, 5 Yr. CAGR % | 31.01 | 7.96 | 7.12 | 10.84 | 5.45 | |||||
Inventory, 5 Yr. CAGR % | 27.01 | 27.96 | 4.87 | 12.61 | 14.42 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.57 | 8.76 | 5.03 | 2.07 | 6.94 | |||||
Total Assets, 5 Yr. CAGR % | 24.15 | 16.34 | 9.64 | 13.37 | 9.55 | |||||
Tangible Book Value, 5 Yr. CAGR % | 30.86 | 24.56 | 19.34 | 14.91 | 11.88 | |||||
Common Equity, 5 Yr. CAGR % | 30.85 | 24.53 | 19.3 | 14.91 | 11.88 | |||||
Cash From Operations, 5 Yr. CAGR % | 32.91 | 49.25 | -4.72 | -8.11 | -4.95 | |||||
Capital Expenditures, 5 Yr. CAGR % | 34.85 | -10.5 | -10.75 | -9.4 | 19.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 40.59 | 37.95 | -38.36 | -6.56 | -19.4 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 49.15 | 44.95 | -39.57 | -7.17 | -18.56 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 0 | 0 | 0 | 31.95 |
Select your edition
All financial news and data tailored to specific country editions
















